Nanomedicine News

RSS

Program to Evaluate HPV-Specific Plasmid DNA Using Nanomedicine Formulation

Genetic Immunity, a leader in immunotherapy technology product development, and DKFZ (German Cancer Research Center, Heidelberg, Germany) signed a collaborative agreement to develop a DNA-based vaccine for the treatment of Human Papilloma Virus (HPV) infection that causes cervical cancer and other cancers of the anus, penis, vulva, vagina, and oropharynx. Present HPV vaccines (Cervarix, Gardasil) have no therapeutic effect on HPV-related diseases, so they will not treat existing diseases or conditions caused by HPV.

15 Oct 2012

Capture of CTCs to be Presented at NEMB Venice Workshop on Cancer Nanotechnology

NaturalNano, announced today that Dr. Michael King of Cornell University will present their recent work today at the First NEMB Venice Workshop on Cancer Nanotechnology in Venice, Italy. (http://nemb2012.cism.it)

15 Oct 2012

New Nanoparticle Shape Control Method Helps Advance Gene Therapy

Researchers from Johns Hopkins and Northwestern universities have discovered how to control the shape of nanoparticles that move DNA through the body and have shown that the shapes of these carriers may make a big difference in how well they work in treating cancer and other diseases.

12 Oct 2012

X-Ray Crystallographic Studies Show Interaction Between Neurotensin and its Receptor

Researchers have published the first highly detailed description of how neurotensin, a neuropeptide hormone which modulates nerve cell activity in the brain, interacts with its receptor.

11 Oct 2012

Vaxxas, Merck Partner to Assess, Develop and Commercialize Nanopatch Vaccine Delivery Platform

Vaxxas, a biotechnology company commercializing a novel vaccine delivery platform, today announced the initiation of a research collaboration with Merck, known as MSD outside the United States and Canada.

11 Oct 2012

Genetic Immunity Announces GMP Approval for its Production Facility of Nanomedicine Ingredients

Genetic Immunity is pleased to announce the GMP approval of its manufacturing facility. The development of the GMP manufacturing process and the facility was financed from a $4 million grant received from the Hungarian Office for Innovation and Technology.

9 Oct 2012

New Research Focuses on Using Nanoparticles to Treat Pediatric Sarcomas

Cameron Cohen, a 14-year-old iPhone applications creator and philanthropist, and his family recently donated $7,500 to fund pediatric cancer research at Mattel Children’s Hospital UCLA.

From University of California, Los Angeles 9 Oct 2012

Novavax Begins Phase II Clinical Study of Nanoparticle-Based RSV Vaccine Candidate

Novavax today announced that enrollment has begun in a Phase 2 dose-ranging clinical trial of its respiratory syncytial virus (RSV) vaccine candidate in women of childbearing age. The study is being conducted in collabor...

From Novavax Inc. 9 Oct 2012

Nanoprobe Inventor to Receive NJIT Overseers Award

Tonight NJIT Research Professor Reginald C. Farrow, PhD, who with his research team have discovered how to make nanoscale arrays of the world's smallest probe for investigating the electrical properties of individual living cells will receive the NJIT Board of Overseers Excellence in Research Prize and Medal.

5 Oct 2012

Mouse Genome Found to Consist of 10-nm Chromatin Fibres

Scientists in Canada and the United States have used three-dimensional imaging techniques to settle a long-standing debate about how DNA and structural proteins are packaged into chromatin fibres.

5 Oct 2012

Nanomedicine News

Program to Evaluate HPV-Specific Plasmid DNA Using Nanomedicine Formulation

Capture of CTCs to be Presented at NEMB Venice Workshop on Cancer Nanotechnology

New Nanoparticle Shape Control Method Helps Advance Gene Therapy

X-Ray Crystallographic Studies Show Interaction Between Neurotensin and its Receptor

Vaxxas, Merck Partner to Assess, Develop and Commercialize Nanopatch Vaccine Delivery Platform

Genetic Immunity Announces GMP Approval for its Production Facility of Nanomedicine Ingredients

New Research Focuses on Using Nanoparticles to Treat Pediatric Sarcomas

Novavax Begins Phase II Clinical Study of Nanoparticle-Based RSV Vaccine Candidate

Nanoprobe Inventor to Receive NJIT Overseers Award

Mouse Genome Found to Consist of 10-nm Chromatin Fibres

Scientists Create the Largest Atomically Thin Gold Films to Make Electronics Weightless and Invisible

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Sustainable Future for Carbon Nanotubes

Sustainable ZnO Nanoparticles for Methylene Blue Cleanup

Enhancing Material Properties through Nanotube Encapsulation

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials